December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Myocilin mt1 Promoter Polymorphisms in Adult-onset Primary Open Angle Glaucoma
Author Affiliations & Notes
  • WL M Alward
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • YH Kwon
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • CL Khanna
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • AT Johnson
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • SS Hayreh
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • MB Zimmerman
    Biostatistics University of Iowa College of Public Health Iowa City IA
  • JH Fingert
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • BR Roos
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • VC Sheffield
    Pediatrics and the HHMI
    University of Iowa College of Medicine Iowa City IA
  • EM Stone
    Ophthalmology
    University of Iowa College of Medicine Iowa City IA
  • Footnotes
    Commercial Relationships    W.L.M. Alward, Alcon F; Y.H. Kwon, None; C.L. Khanna, None; A.T. Johnson, None; S.S. Hayreh, None; M.B. Zimmerman, None; J.H. Fingert, None; B.R. Roos, None; V.C. Sheffield, Alcon F; E.M. Stone, Alcon F. Grant Identification: NIH Grant EY10564
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3012. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      WL M Alward, YH Kwon, CL Khanna, AT Johnson, SS Hayreh, MB Zimmerman, JH Fingert, BR Roos, VC Sheffield, EM Stone; Myocilin mt1 Promoter Polymorphisms in Adult-onset Primary Open Angle Glaucoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3012.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:A polymorphism in the promoter region of the myocilin glaucoma gene (MYOC.mt1) has recently been reported to portend a poor response to glaucoma treatment. We sought to determine whether adult-onset primary open angle glaucoma (POAG) patients with the MYOC.mt1 promoter polymorphism differed from other POAG patients in any measure of glaucoma severity. Methods:We recruited a consecutive, unselected series of 394 adult-onset POAG patients. The prevalence of the MYOC.mt1 promoter polymorphism was measured in these patients and 92 normal control individuals from the same population. Clinical features of patients with the MYOC.mt1 promoter polymorphism were compared to those without the polymorphism. These features included: age at diagnosis, age at first treatment, highest IOP, C/D ratio, visual field loss, number of medications, need for trabeculoplasty, and number of surgeries. Female patients were looked at as a subgroup because of a published finding suggesting that an estrogen response element in the promoter region might cause them to exhibit a more deleterious response to this polymorphism. Results:The MYOC.mt1 promoter polymorphism was found in 61 (15.82%) of 394 POAG patients and 22 (23.91%) of 92 normal controls. The clinical features of adult-onset POAG patients with the MYOC.mt1 promoter polymorphism were no different than those without the polymorphism. When women were examined separately there was again no MYOC.mt1 promoter polymorphism effect found on any of the clinical features measured. Conclusion:The MYOC.mt1 promoter polymorphism is a common and insignificant DNA sequence variation, found as often among normal volunteers as among POAG patients. POAG patients with the MYOC.mt1 promoter polymorphism were no different than those without this variant in any of the clinical features measured. Testing for the MYOC.mt1 promoter polymorphism does not appear to be of clinical value.

Keywords: 420 genetics • 480 mutations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×